Primatene Mist

Epinephrine Inhalation · EPINEPHRINE 125 ug/1 · Aerosol · Respiratory (Inhalation) · Armstrong Pharmaceuticals, Inc.

NDC 17270-5512-00 · 12 CARTON in 1 PACKAGE / 1 INHALER in 1 CARTON / 160 AEROSOL in 1 INHALER · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for epinephrine (other) in the next 90 days

sole-source market · price up 6% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application: NDA205920
TE code: —
Approval date: Nov 7, 2018
Patents / exclusivity: 1 patents, 0 exclusivities

Type	Number / code	Expires
patent	8367734	Jan 26, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Epinephrine Inhalation (Aerosol)

Labeler	Strength	First seen	Last seen
Armstrong Pharmaceuticals, Inc.	EPINEPHRINE 125 ug/1	Jul 15, 2026	Sep 3, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Primatene Mist — NDC 17270-5512-00," retrieved September 3, 2026, https://drugdashboards.com/drug/17270551200.

Free to cite with attribution — see how the data is put together.